Implant dose describes the number of implanted ions delivered per unit area. Electrically active doping describes dopants participating in the semiconductor's electrical behavior after the relevant processing. These are different quantities, so a larger delivered dose does not by itself prove a proportionally larger carrier population.
Delivered ions are not an electrical result
An implanted species comes to rest through interactions with the solid and can create lattice damage. Its eventual location and chemical state matter. A dopant atom occupying an electrically useful configuration is not equivalent to one remaining in an inactive cluster or an unsuitable environment.
Some implanted species are used primarily for other material effects rather than as electrical dopants. Even when the species is a dopant, delivery and activation remain distinct stages of the explanation.
Process map
A selected 2-step learning trail in 28nm Planar Flow
Locate the introduction of background well dopants before subsequent thermal stabilization.
Real step names, layer-by-layer cross-sections, and rationale live inside the 28nm Planar Flow course, unlocked by account access.
Keep the different profiles separate
| Quantity | What is counted or described? | Missing information |
|---|---|---|
| Implant dose | Delivered ions per area | Final distribution and electrical activity |
| Chemical dopant profile | Where the dopant species is present | Which fraction is electrically active |
| Active dopant profile | Electrically participating dopants | Carrier mobility and full transport behavior |
| Carrier population | Mobile electrons or holes under stated conditions | The complete chemical inventory |
Compensation adds another distinction: donors and acceptors can both be present, while their electrical balance differs from their total chemical count. Carrier occupation also depends on the state of the semiconductor. These relationships should not be collapsed into a single number.
Annealing changes more than one variable
Subsequent thermal processing can help repair damage and change dopant activation, while also redistributing dopants. Some species can segregate at interfaces or form inactive configurations. The final electrical profile is therefore a result of the combined material history, not a direct copy of the incoming implant distribution.
This explains why “increase the dose” is not a complete response to poor conduction. Resistance also depends on activation, mobility, geometry and the path through which current flows. A chemical concentration increase may leave the limiting mechanism largely unchanged.
A comparison that avoids a false conclusion
Imagine two samples with similar measured chemical dopant profiles but different electrical responses. That observation does not immediately contradict the chemical measurement. The active fraction, defects, compensation or carrier transport may differ.
Now imagine two samples with different delivered doses but similar conductivity. One cannot conclude that the implant step had no effect. Several contributions can offset one another. The useful next step in reasoning is to identify which measurement characterizes delivery, which characterizes chemical presence, and which characterizes electrical behavior.
The example is intentionally qualitative. It explains why independent observations are needed without prescribing a manufacturing dose or an annealing recipe.
Source links
References
Silicon VLSI Technology - Full
James D. Plummer, Michael D. Deal, Peter B. Griffin
Silicon VLSI Technology · ISBN 978-0130850379
Physics of Semiconductor Devices - Full
S. M. Sze, Kwok K. Ng
Physics of Semiconductor Devices · ISBN 978-0-471-14323-9